Parthenolide - Revision history

Lazy at 08:30, 18 January 2025

2025-01-18T08:30:54Z

← Older revision		Revision as of 01:30, 18 January 2025
Line 21:		Line 21:
	* [Parthenolide in cancer prevention and therapy](https://cancerpreventionresearch.aacrjournals.org/)		* [Parthenolide in cancer prevention and therapy](https://cancerpreventionresearch.aacrjournals.org/)
	\|toxicity_explanation=As a natural compound, parthenolide is generally considered to have low toxicity. However, due to its potent biological activities, it should be used with caution, and further studies are needed to fully understand its safety profile in clinical settings.		\|toxicity_explanation=As a natural compound, parthenolide is generally considered to have low toxicity. However, due to its potent biological activities, it should be used with caution, and further studies are needed to fully understand its safety profile in clinical settings.
	}}		\|overview=Parthenolide, derived from the feverfew plant, is an investigational compound primarily used in research settings for its potential anti-cancer properties, particularly in targeting glioblastoma and glioma stem cells. While it has shown promise in preclinical studies by inducing apoptosis and modulating key survival pathways, it is not FDA-approved for treatment, and its clinical efficacy and safety are still under investigation.}}

69.163.248.232: Updated category= to treatment_category= in TreatmentInfo template

2024-11-12T18:50:19Z

Updated category= to treatment_category= in TreatmentInfo template

← Older revision		Revision as of 11:50, 12 November 2024
Line 15:		Line 15:
	This naturally occurring compound from the feverfew plant has garnered interest for its strong anti-inflammatory and potential anti-cancer properties. In glioblastoma research, parthenolide's ability to specifically target cancer stem cells has been a focus, with studies showing its capacity to disrupt crucial survival pathways in these cells. The development of effective delivery mechanisms and formulations to improve bioavailability and therapeutic efficacy in patients remains a significant research area.		This naturally occurring compound from the feverfew plant has garnered interest for its strong anti-inflammatory and potential anti-cancer properties. In glioblastoma research, parthenolide's ability to specifically target cancer stem cells has been a focus, with studies showing its capacity to disrupt crucial survival pathways in these cells. The development of effective delivery mechanisms and formulations to improve bioavailability and therapeutic efficacy in patients remains a significant research area.

	\|~~category~~=Nutraceuticals		\|treatment_category=Nutraceuticals
	\|links=* [Preclinical study on Parthenolide's impact in glioblastoma](https://www.ncbi.nlm.nih.gov/pubmed/)		\|links=* [Preclinical study on Parthenolide's impact in glioblastoma](https://www.ncbi.nlm.nih.gov/pubmed/)
	* [Review of Parthenolide's mechanisms of action in cancer therapy](https://www.ncbi.nlm.nih.gov/pmc/articles/)		* [Review of Parthenolide's mechanisms of action in cancer therapy](https://www.ncbi.nlm.nih.gov/pmc/articles/)

Lazy: Created page with "{{TreatmentInfo |drug_name=Parthenolide |FDA_approval=No (Used primarily in research settings; not FDA-approved for cancer treatment) |used_for=Investigational use in cancer treatment, specifically for its effects on glioblastoma and glioma stem cells |clinical_trial_phase=Preclinical studies |clinical_trial_explanation=Parthenolide is being studied for its potential anti-cancer properties in glioblastoma, particularly focusing on its ability to target and kill glioma st..."

2024-04-28T17:57:06Z

Created page with "{{TreatmentInfo |drug_name=Parthenolide |FDA_approval=No (Used primarily in research settings; not FDA-approved for cancer treatment) |used_for=Investigational use in cancer treatment, specifically for its effects on glioblastoma and glioma stem cells |clinical_trial_phase=Preclinical studies |clinical_trial_explanation=Parthenolide is being studied for its potential anti-cancer properties in glioblastoma, particularly focusing on its ability to target and kill glioma st..."

New page

{{TreatmentInfo
|drug_name=Parthenolide
|FDA_approval=No (Used primarily in research settings; not FDA-approved for cancer treatment)
|used_for=Investigational use in cancer treatment, specifically for its effects on glioblastoma and glioma stem cells
|clinical_trial_phase=Preclinical studies
|clinical_trial_explanation=Parthenolide is being studied for its potential anti-cancer properties in glioblastoma, particularly focusing on its ability to target and kill glioma stem cells. Research has examined its role in inducing apoptosis and inhibiting the NF-kB pathway, which is crucial for cancer cell survival and proliferation.
|common_side_effects=Potential side effects are not well-documented due to its primary use in research; however, as with many natural compounds, potential for gastrointestinal upset exists.
|OS_with=Not applicable; current research is primarily in preclinical stages focusing on cellular mechanisms
|PFS_with=Not applicable; studies are ongoing to determine its effect on disease progression in preclinical models
|usefulness_rating=3
|usefulness_explanation=Parthenolide has shown potential in laboratory studies for its ability to induce apoptosis in cancer cells, particularly glioblastoma stem cells. Its effectiveness in clinical settings remains to be fully established, making its current utility in treatment speculative but promising.
|toxicity_level=2
|notes=Parthenolide, derived from the feverfew plant, is investigated for its potent anti-inflammatory and anti-cancer properties. Its action against glioma stem cells includes modulation of pathways critical for cell survival and resistance to conventional therapies, offering a novel approach to glioblastoma treatment that warrants further clinical exploration.

This naturally occurring compound from the feverfew plant has garnered interest for its strong anti-inflammatory and potential anti-cancer properties. In glioblastoma research, parthenolide's ability to specifically target cancer stem cells has been a focus, with studies showing its capacity to disrupt crucial survival pathways in these cells. The development of effective delivery mechanisms and formulations to improve bioavailability and therapeutic efficacy in patients remains a significant research area.

|category=Nutraceuticals
|links=* [Preclinical study on Parthenolide's impact in glioblastoma](https://www.ncbi.nlm.nih.gov/pubmed/)
* [Review of Parthenolide's mechanisms of action in cancer therapy](https://www.ncbi.nlm.nih.gov/pmc/articles/)
* [Parthenolide and its potential therapeutic effects on glioblastoma](https://www.sciencedirect.com/science/article/pii/)
* [Parthenolide in cancer prevention and therapy](https://cancerpreventionresearch.aacrjournals.org/)
|toxicity_explanation=As a natural compound, parthenolide is generally considered to have low toxicity. However, due to its potent biological activities, it should be used with caution, and further studies are needed to fully understand its safety profile in clinical settings.
}}